BioCardia Inc
BCDA
NASDAQ
Biotechnology
$0.97
USD
+0.04 (+4.82%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $13.17M
Volume 157.6K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-7.34M
TTM
+16.5%
YoY
Operating Cash Flow
$-7.56M
TTM
+9.0%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | -100.0% | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 0.7 | 0.6 | 0.9 | 1.0 | 0.7 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 2.1 | 1.5 | 2.0 | 2.3 | 1.6 |
Operating Income | -2.1 | -1.5 | -2.0 | -2.3 | -1.6 |
EBITDA | -2.0 | -1.5 | -2.0 | -2.3 | -1.6 |
Other Income / Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Other Income / Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Income Before Income Taxes | -2.0 | -1.5 | -2.0 | -2.3 | -1.6 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -2.0 | -1.5 | -2.0 | -2.3 | -1.6 |
Consolidated Net Income / Loss | -2.0 | -1.5 | -2.0 | -2.3 | -1.6 |
Net Income Attributable to Common Shareholders | -2.0 | -1.5 | -2.0 | -2.3 | -1.6 |
Basic EPS | -$0.40 | -$0.24 | -$0.19 | -$0.21 | -$0.13 |
Diluted EPS | -$0.40 | -$0.24 | -$0.19 | -$0.21 | -$0.13 |
Basic Shares Outstanding | 5.1M | 6.3M | 10.7M | 10.8M | 12.1M |
Diluted Shares Outstanding | 5.1M | 6.3M | 10.7M | 10.8M | 12.1M |